INR 1.02
(4.08%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 19.93 Million INR | 279.63% |
2022 | 353 Thousand INR | -528.24% |
2021 | 1.71 Million INR | 108.19% |
2020 | 4.5 Million INR | -2456.63% |
2019 | 1.34 Million INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 3.58 Million INR | -34.37% |
2024 Q2 | 4.81 Million INR | 35.43% |
2023 Q2 | 451.3 Thousand INR | 31.57% |
2023 Q3 | 2.97 Million INR | 559.96% |
2023 Q1 | 343 Thousand INR | 104.74% |
2023 Q4 | 5.41 Million INR | 81.91% |
2023 FY | - INR | 278.46% |
2022 Q3 | -549 Thousand INR | -144.27% |
2022 FY | - INR | -528.24% |
2022 Q4 | -7.23 Million INR | -1218.58% |
2022 Q2 | 1.24 Million INR | 151.88% |
2022 Q1 | -2.39 Million INR | 0.0% |
2021 FY | - INR | 108.19% |
2020 FY | - INR | -2456.63% |
2019 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 36.55 Million INR | 45.459% |
Checkpoint Trends Limited | 297.07 Thousand INR | -6611.886% |
Everest Organics Limited | 118.72 Million INR | 83.206% |
GUJARAT INJECT (KERALA) LTD. | 1.05 Million INR | -1794.21% |
NATURO INDIABULL LIMITED | 14.68 Million INR | -35.76% |
NEXUS SURGICAL AND MEDICARE LI | 2.98 Million INR | -568.659% |
Rama Vision Limited | 67.79 Million INR | 70.588% |
Vivo Bio Tech Limited | 212.99 Million INR | 90.639% |